Document is current
Any future updates will be listed below
-
Authors
Bohnsack, Richard N.
Misra, Sandeep K.
Liu, Jianfang
Ishihara-Aoki, Mayumi
Pereckas, Michaela
Aoki, Kazuhiro
Ren, Gang
Sharp, Joshua S.
Dahms, Nancy M. https://orcid.org/0000-0001-6819-0590
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01HL115153, R01GM127267, R01DK042667)
- License Information
-
More Information
Article History
Received: 20 May 2024
Accepted: 3 October 2024
First Online: 6 November 2024
Declarations
:
: N.M.D. is a member of the scientific advisory board of M6P Therapeutics. J.S.S. discloses a significant interest in GenNext Technologies, Inc., a company commercializing technologies for protein higher-order structure analysis. R.N.B., S.K.M., J.L, M.I.-A., M.P., K.A., and G.R. declare no competing interests.
